ScoreWhy is Emmessar Biotech & Nutrition Ltd ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-32.98%
EBIT Growth (5y)
-43.03%
EBIT to Interest (avg)
-0.43
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0.34
Tax Ratio
46.88%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.20%
ROCE (avg)
-58.72%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
60
Industry P/E
39
Price to Book Value
1.72
EV to EBIT
-4.74
EV to EBITDA
-5.08
EV to Capital Employed
6.40
EV to Sales
6.40
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-135.00%
ROE (Latest)
2.88%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-4What is not working for the Company
OPERATING CF(Y)
Lowest at Rs 0.22 Cr
PBDIT(Q)
Lowest at Rs -0.37 cr.
PBT LESS OI(Q)
Lowest at Rs -0.40 cr.
Loading Valuation Snapshot...
Here's what is not working for Emmessar Biotech
Operating Cash Flow - Annually
Lowest at Rs 0.22 Cr
in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Lowest at Rs -0.37 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.40 cr.
in the last five quartersMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
